Literature DB >> 9188838

Determination of N(G),N(G)-dimethylarginine in human plasma by high-performance liquid chromatography.

B M Chen1, L W Xia, R Q Zhao.   

Abstract

N(G),N(G)-Dimethylarginine (asymmetric dimethylarginine, ADMA) can be directly separated and measured from deproteinized human plasma using o-phthaldialdehyde-mercaptoethanol (OPA reagent) as a fluorogenic reagent by reversed-phase high-performance liquid chromatography. The mean recovery of ADMA was over 96% and the inter- and intra-assay coefficients of variation of amounts were lower than 3.80% and those of retention time were below 0.37% for five runs. The detection limit of the assay is 1 pmol when the signal-to-noise ratio is 3:1. It was observed that the concentration of ADMA was significantly elevated in plasma of patients with pregnancy induced hypertension (PIH) in contrast to healthy pregnant women.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9188838     DOI: 10.1016/s0378-4347(96)00531-2

Source DB:  PubMed          Journal:  J Chromatogr B Biomed Sci Appl        ISSN: 1387-2273


  20 in total

1.  Effect of fenofibrate on LDL-induced endothelial dysfunction in rats.

Authors:  Tian-Lun Yang; Mei-Fang Chen; Bai-Ling Luo; Jing Yu; Jun-Lin Jiang; Yuan-Jian Li
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2004-08-14       Impact factor: 3.000

2.  Protective effect of HDL on endothelial NO production: the role of DDAH/ADMA pathway.

Authors:  Zhen-Yu Peng; Shui-Ping Zhao; Bai-Mei He; Dao-Quan Peng; Min Hu
Journal:  Mol Cell Biochem       Date:  2011-01-25       Impact factor: 3.396

3.  Plasma asymmetric dimethylarginine levels are increased in neonates with bronchopulmonary dysplasia-associated pulmonary hypertension.

Authors:  Jennifer K Trittmann; Eric Peterson; Lynette K Rogers; Bernadette Chen; Carl H Backes; Mark A Klebanoff; Leif D Nelin
Journal:  J Pediatr       Date:  2014-10-11       Impact factor: 4.406

4.  The effect of taurine on the relationship between NO, ADMA and homocysteine in endotoxin-mediated inflammation in HUVEC cultures.

Authors:  Ozge Tugce Pasaoglu; Nurten Turkozkan; Mustafa Ark; Belgin Polat; Mehmet Agilli; Halil Yaman
Journal:  Inflammation       Date:  2014-10       Impact factor: 4.092

5.  Asymmetric dimethylarginine concentrations are elevated in women with gestational diabetes.

Authors:  Mujde Akturk; Alev Altinova; Ismail Mert; Aylin Dincel; Ayla Sargin; Umran Buyukkagnici; Metin Arslan; Nuri Danisman
Journal:  Endocrine       Date:  2010-07-11       Impact factor: 3.633

6.  Elevated Levels of ADMA Are Associated with Lower DDAH2 and Higher PRMT1 in LPS-Induced Endometritis Rats.

Authors:  Hong-Bo Xiao; Guo-Guang Sui; Xiang-Yang Lu; Zhi-Liang Sun
Journal:  Inflammation       Date:  2018-02       Impact factor: 4.092

7.  Circulating nitric oxide (NO), asymmetric dimethylarginine (ADMA), homocysteine, and oxidative status in obstructive sleep apnea-hypopnea syndrome (OSAHS).

Authors:  Yeşim Ozkan; Hikmet Firat; Bolkan Simşek; Meral Torun; Sevgi Yardim-Akaydin
Journal:  Sleep Breath       Date:  2008-05       Impact factor: 2.816

8.  Protective effects of daviditin A against endothelial damage induced by lysophosphatidylcholine.

Authors:  De-Jian Jiang; Jun-Lin Jiang; Gui-Shan Tan; Yan-Hua Du; Kang-Ping Xu; Yuan-Jian Li
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-05-15       Impact factor: 3.000

9.  Pressure-related increase of asymmetric dimethylarginine caused by hyperbaric oxygen in the rat brain: a possible neuroprotective mechanism.

Authors:  Emin Ozgür Akgül; Erdinc Cakir; Omer Ozcan; Halil Yaman; Yasemin Gülcan Kurt; Sükrü Oter; Ahmet Korkmaz; Cumhur Bilgi; Mehmet Kemal Erbil
Journal:  Neurochem Res       Date:  2007-06-13       Impact factor: 3.996

10.  ADMA levels correlate with proteinuria, secondary amyloidosis, and endothelial dysfunction.

Authors:  Mahmut Ilker Yilmaz; Alper Sonmez; Mutlu Saglam; Abdul R Qureshi; Juan Jesus Carrero; Kayser Caglar; Tayfun Eyileten; Erdinc Cakir; Yusuf Oguz; Abdulgaffar Vural; Mujdat Yenicesu; Bengt Lindholm; Peter Stenvinkel; Jonas Axelsson
Journal:  J Am Soc Nephrol       Date:  2008-01-16       Impact factor: 10.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.